Ana M Suelves
Overview
Explore the profile of Ana M Suelves including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
169
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalavar M, El Khatib B, Suelves A, Yanoga F
Am J Ophthalmol Case Rep
. 2023 Sep;
32:101915.
PMID: 37663997
Purpose: Several ophthalmological complications of coronavirus disease 2019 (COVID-19) involving the anterior and posterior segment have been reported in the literature. We present two patients with Purtscher-like retinopathy presenting with...
2.
White C, Suelves A, Johnson B, Moorthy R
Retina
. 2018 Mar;
39(5):1027-1030.
PMID: 29489564
No abstract available.
3.
Suelves A, Shulman J
Eye Brain
. 2017 May;
8:37-43.
PMID: 28539800
Retinopathy of prematurity (ROP) is a complex disease characterized by an aberrant developmental retinal angiogenesis in preterm infants and can carry significant visual morbidity, including retinal detachment and blindness. Though...
4.
Suelves A, Lamba N, Meese H, Foster C, Gonzalez-Martin J, Diaz-Llopis M, et al.
J AAPOS
. 2016 May;
20(3):232-238.e1.
PMID: 27164426
Purpose: To analyze factors predictive of having treatment-resistant uveitis in patients with juvenile idiopathic arthritis (JIA)-associated uveitis. Methods: The medical records of patients diagnosed with JIA-associated uveitis treated at a...
5.
Guerra J, Suelves A, Bella A, Lolo D
BMJ Case Rep
. 2014 May;
2014.
PMID: 24842353
Tyrosine kinase inhibitors are novel antineoplastic drugs that make use of the molecular abnormalities that have been discovered in certain types of tumours. These agents are associated with important dermatological...
6.
Suelves A, Gregori E, Diaz-Llopis M
Ophthalmology
. 2013 Nov;
120(12):e83-e84.
PMID: 24246830
No abstract available.
7.
Suelves A, Siddique S, Schurko B, Foster C
J Cataract Refract Surg
. 2013 Nov;
40(1):77-81.
PMID: 24238942
Purpose: To compare the incidence of long-term complications after cataract surgery with primary anterior chamber intraocular lens (AC IOL) implantation in uveitic patients and patients without a history of intraocular...
8.
Kruh J, Yang P, Suelves A, Foster C
Ophthalmology
. 2013 Sep;
121(1):358-364.
PMID: 24011995
Objective: To establish the safety and efficacy of infliximab for the treatment of refractory noninfectious uveitis. Design: Retrospective, interventional, noncomparative cohort study. Participants: Eighty-eight patients from a single-center private practice....
9.
Arafat S, Suelves A, Spurr-Michaud S, Chodosh J, Foster C, Dohlman C, et al.
Ophthalmology
. 2013 Aug;
121(1):79-87.
PMID: 23962653
Objective: To investigate the levels of matrix metalloproteinases (MMPs), myeloperoxidase (MPO), and tissue inhibitor of metalloproteinase-1 (TIMP-1) in tears of patients with Stevens-Johnson syndrome (SJS) and ocular cicatricial pemphigoid (OCP)....
10.
Suelves A, Arcinue C, Gonzalez-Martin J, Kruh J, Foster C
Ophthalmology
. 2013 Apr;
120(6):1201-9.
PMID: 23601800
Purpose: To analyze the success rate of pulsed intravenous (IV) cyclophosphamide (CyP) for noninfectious ocular inflammatory disease and to identify risk factors for failure of therapy. Design: Retrospective, interventional, noncomparative...